Last reviewed · How we verify
NCT04205526: ConTRAstroke
Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke
NA trial testing Active rTMS in Feasibility Study in 49 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Thiel, Alexander, M.D. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 49 |
| Start date | 1 January 2021 |
| Primary completion | 1 April 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Active rTMS
- Sham TMS
Conditions studied
- Feasibility Study — all drugs for Feasibility Study →
Sponsor
Thiel, Alexander, M.D.
Who can join
Adults 18 to 90, any sex, with Feasibility Study. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The CanStim consensus working group (multidisciplinary team of experts in rTMS from institutions across Canada) developed consensus recommendations for a protocol to deliver rTMS as an adjunct to physiotherapy to improve arm function in a Pan-Canadian stroke rehabilitation clinical trial. The overall goal of this multi-center feasibility trial is not to demonstrate that rTMS is effective, but to demonstrate that each site can recruit the assigned number of patients within a certain period, perform the stimulation procedure in conjunction with the protocol-specified physiotherapy intervention, complete the therapy protocol and enter complete datasets for each patient into the CanStim database. A secondary aim is to identify potential weaknesses of the consensus protocol that may need to be modified before performing a larger scale trial testing for the efficacy of the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04205526
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Active rTMS
Trials testing the same drug.
- NCT07113990 — Electroacupuncture and rTMS for Post-Stroke Motor Recovery · NA · recruiting
- NCT06999772 — Combining Brain Stimulation and Physiotherapy for the Management of Chronic Low Back Pain · NA · recruiting
- NCT06961916 — Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) · NA · recruiting
- NCT06247904 — NIBS Therapy in Subacute Spinal Cord Injury · NA · enrolling by invitation
- NCT06956300 — TMS for Cognitive Decline in Aging and Preclinical AD · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04205526 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thiel, Alexander, M.D.
- Last refreshed: 23 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04205526.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing